vs
DXP ENTERPRISES INC（DXPE）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
DXP ENTERPRISES INCの直近四半期売上が大きい（$527.4M vs $493.8M、Pediatrix Medical Group, Inc.の約1.1倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 4.3%、差は2.5%）。DXP ENTERPRISES INCの前年同期比売上増加率が高い（12.0% vs -1.7%）。過去8四半期でDXP ENTERPRISES INCの売上複合成長率が高い（13.1% vs -0.1%）
DXPエンタープライズ社は、保守・修理・運用（MRO）向け消耗品、流体制御機器、ポンプシステム及び関連技術サービスを提供する大手産業流通企業です。製造業、エネルギー、鉱業、建設などの分野の顧客を中心に、北米を主な市場として事業を展開しています。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
DXPE vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $527.4M | $493.8M |
| 純利益 | $22.8M | $33.7M |
| 粗利率 | 31.6% | — |
| 営業利益率 | 8.8% | 9.9% |
| 純利益率 | 4.3% | 6.8% |
| 売上前年比 | 12.0% | -1.7% |
| 純利益前年比 | 6.9% | 10.5% |
| EPS（希薄化後） | $1.38 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $527.4M | $493.8M | ||
| Q3 25 | $513.7M | $492.9M | ||
| Q2 25 | $498.7M | $468.8M | ||
| Q1 25 | $476.6M | $458.4M | ||
| Q4 24 | $470.9M | $502.4M | ||
| Q3 24 | $472.9M | $511.2M | ||
| Q2 24 | $445.6M | $504.3M | ||
| Q1 24 | $412.6M | $495.1M |
| Q4 25 | $22.8M | $33.7M | ||
| Q3 25 | $21.6M | $71.7M | ||
| Q2 25 | $23.6M | $39.3M | ||
| Q1 25 | $20.6M | $20.7M | ||
| Q4 24 | $21.4M | $30.5M | ||
| Q3 24 | $21.1M | $19.4M | ||
| Q2 24 | $16.7M | $-153.0M | ||
| Q1 24 | $11.3M | $4.0M |
| Q4 25 | 31.6% | — | ||
| Q3 25 | 31.4% | — | ||
| Q2 25 | 31.6% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.9% | — | ||
| Q2 24 | 30.9% | — | ||
| Q1 24 | 30.0% | — |
| Q4 25 | 8.8% | 9.9% | ||
| Q3 25 | 8.5% | 13.8% | ||
| Q2 25 | 9.2% | 12.8% | ||
| Q1 25 | 8.5% | 7.0% | ||
| Q4 24 | 8.3% | 7.8% | ||
| Q3 24 | 8.4% | 6.6% | ||
| Q2 24 | 8.4% | -31.3% | ||
| Q1 24 | 7.1% | 3.2% |
| Q4 25 | 4.3% | 6.8% | ||
| Q3 25 | 4.2% | 14.5% | ||
| Q2 25 | 4.7% | 8.4% | ||
| Q1 25 | 4.3% | 4.5% | ||
| Q4 24 | 4.5% | 6.1% | ||
| Q3 24 | 4.5% | 3.8% | ||
| Q2 24 | 3.7% | -30.3% | ||
| Q1 24 | 2.7% | 0.8% |
| Q4 25 | $1.38 | $0.40 | ||
| Q3 25 | $1.31 | $0.84 | ||
| Q2 25 | $1.43 | $0.46 | ||
| Q1 25 | $1.25 | $0.24 | ||
| Q4 24 | $1.28 | $0.37 | ||
| Q3 24 | $1.27 | $0.23 | ||
| Q2 24 | $1.00 | $-1.84 | ||
| Q1 24 | $0.67 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $303.8M | $375.2M |
| 総負債低いほど良い | — | $570.5M |
| 株主資本純資産 | $498.4M | $865.9M |
| 総資産 | $1.7B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $303.8M | $375.2M | ||
| Q3 25 | $123.8M | $340.1M | ||
| Q2 25 | $112.9M | $224.7M | ||
| Q1 25 | $114.3M | $99.0M | ||
| Q4 24 | $148.3M | $229.9M | ||
| Q3 24 | $35.0M | $103.8M | ||
| Q2 24 | $49.9M | $19.4M | ||
| Q1 24 | $139.7M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $498.4M | $865.9M | ||
| Q3 25 | $488.3M | $890.7M | ||
| Q2 25 | $468.1M | $833.8M | ||
| Q1 25 | $444.7M | $789.2M | ||
| Q4 24 | $422.8M | $764.9M | ||
| Q3 24 | $402.4M | $732.5M | ||
| Q2 24 | $384.7M | $706.5M | ||
| Q1 24 | $375.5M | $856.2M |
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $37.8M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $34.5M | — |
| FCFマージンFCF / 売上 | 6.5% | — |
| 設備投資強度設備投資 / 売上 | 0.6% | — |
| キャッシュ転換率営業CF / 純利益 | 1.65× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $54.0M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $37.8M | $114.1M | ||
| Q3 25 | $34.9M | $137.3M | ||
| Q2 25 | $18.6M | $137.2M | ||
| Q1 25 | $3.0M | $-117.5M | ||
| Q4 24 | $32.1M | $133.0M | ||
| Q3 24 | $28.3M | $91.8M | ||
| Q2 24 | $14.7M | $107.0M | ||
| Q1 24 | $27.0M | $-125.2M |
| Q4 25 | $34.5M | — | ||
| Q3 25 | $28.1M | — | ||
| Q2 25 | $8.3M | — | ||
| Q1 25 | $-16.9M | — | ||
| Q4 24 | $22.7M | — | ||
| Q3 24 | $24.4M | — | ||
| Q2 24 | $5.9M | — | ||
| Q1 24 | $24.1M | — |
| Q4 25 | 6.5% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 1.65× | 3.39× | ||
| Q3 25 | 1.61× | 1.91× | ||
| Q2 25 | 0.79× | 3.49× | ||
| Q1 25 | 0.14× | -5.66× | ||
| Q4 24 | 1.50× | 4.36× | ||
| Q3 24 | 1.34× | 4.72× | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 2.38× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
DXPE
| Service Centers | $356.2M | 68% |
| Innovative Pumping Solutions | $110.0M | 21% |
| Supply Chain Services | $61.2M | 12% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
